2.510SEK-2.71%Mkt Cap: 606.84M SEKP/E: —Last update: 2026-05-13
Enzymatica AB (publ), a life science company, develops and sells medical devices for infection-related diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses …
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-8.33
PEG—
P/B5.47
P/S11.44
EV/EBITDA-13.07
EV/Revenue10.96
EPS (TTM)-0.20
EPS (Forward)-0.30
Cash Flow & Leverage
FCF Yield-3.66%
FCF Margin-41.85%
Operating CF-40.97M SEK
CapEx (TTM)231.00K SEK
Net Debt/EBITDA0.57
Net Debt-25.39M SEK
Technical
SMA 502.616 (-4.1%)
SMA 2002.206 (+13.8%)
Beta-0.37
S&P 52W Chg24.23%
Avg Vol (30d)134.60K
Avg Vol (10d)121.65K
Technical Indicators
RSI (14)42.8
MACD-0.0226
MACD Signal0.0060
MACD Hist.-0.0286
BB Upper2.912 SEK
BB Middle2.668 SEK
BB Lower2.425 SEK
BB Width18.22%
ATR (14)0.1652 SEK
Vol Ratio (20d)0.35x
52W Range
1.60047% of range3.520
52W High3.520 SEK
52W Low1.600 SEK
Profitability
Gross Margin61.45%
EBITDA Margin-83.82%
Profit Margin-96.27%
Oper. Margin-118.64%
ROE-41.79%
ROA-36.55%
Revenue Growth-6.80%
Earnings Growth—
Balance Sheet
Debt/Equity0.01
Current Ratio3.05
Quick Ratio2.09
Book Value/Sh0.4570 SEK
Cash/Share0.1070 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.242.74M
Float106.48M
Insiders69.40%
Institutions4.33%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap606.84M SEK
Enterprise Value581.44M SEK
Revenue (TTM)53.06M SEK
Gross Profit33.13M SEK
Net Income (TTM)-51.89M SEK
Revenue/Share0.2190 SEK
Fiscal Year EndMar 2021
MR QuarterMar 2026
Employees21
Last Price2.510 SEK
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0003943620